Daily life restrictions are common and associated with health concerns and dietary challenges in adult celiac disease patients diagnosed in childhood by Leinonen, Heini et al.
nutrients
Article
Daily Life Restrictions are Common and Associated
with Health Concerns and Dietary Challenges in
Adult Celiac Disease Patients Diagnosed
in Childhood
Heini Leinonen 1,2, Laura Kivelä 2,3,*, Marja-Leena Lähdeaho 2, Heini Huhtala 4,
Katri Kaukinen 1,5,6 and Kalle Kurppa 1,2,7
1 Faculty of Medicine and Health Technology, Tampere University, 33014 Tampere, Finland
2 Center for Child Health Research, Tampere University and Department of Pediatrics, Tampere University
Hospital, 33014 Tampere, Finland
3 Pediatric Research Center, Children’s Hospital, University of Helsinki and Helsinki University Hospital,
00029 Helsinki, Finland
4 Faculty of Social Sciences, Tampere University, 33014 Tampere, Finland
5 Department of Internal Medicine, Tampere University Hospital, 33014 Tampere, Finland
6 Celiac Disease Research Center, Tampere University, 33014 Tampere, Finland
7 The University Consortium of Seinäjoki, 60320 Seinäjoki, Finland
* Correspondence: laura.kivela@fimnet.fi; Tel.: +358-94711
Received: 28 June 2019; Accepted: 23 July 2019; Published: 25 July 2019


Abstract: The prevalence and associated factors of daily life restrictions due to a gluten-free diet
in adult celiac disease patients diagnosed in childhood are poorly known. We investigated these
issues by collecting the medical data of 955 pediatric patients and sending questionnaires evaluating
various health outcomes to the 559 patients who had reached adulthood. Of the 231 respondents,
46% reported everyday life restrictions caused by dietary treatment. Compared with those without
restrictions, they more often had anemia at diagnosis (37% vs. 22%, p = 0.014), but the groups were
comparable in other diagnostic features. In adulthood, patients with restrictions reported more overall
symptoms (32% vs. 17%, p = 0.006), although the symptoms measured with the Gastrointestinal
Symptom Rating Scale questionnaire were comparable. Despite strict dietary adherence in both
groups, the experience of restrictions was associated with dietary challenges (34% vs. 9%, p < 0.001),
health concerns (22% vs. 13%, p = 0.050), and lower vitality scores in the Psychological General
Well-Being questionnaire. The groups did not differ in their current age, socioeconomic status, family
history of celiac disease, general health or health-related lifestyle, the presence of co-morbidities,
or regular follow up. Our results encourage healthcare professionals to discuss the possible health
concerns and dietary challenges with patients to avoid unnecessary daily life restrictions, especially
when young patients start to take responsibility for their treatment.
Keywords: celiac disease; daily life; experience; follow up; gluten-free diet; restrictions; transition
1. Introduction
During the past few decades, celiac disease has gradually become one of the most common
chronic gastrointestinal diseases [1]. This is mostly due to improved case findings and at-risk
group screenings, which have simultaneously resulted in earlier diagnoses with often a mild clinical
presentation [2,3]. Although, in a broad sense, this is a positive trend, such a change may affect
attitudes towards the diagnosis and treatment of celiac disease. A strict gluten-free diet is challenging
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and requires considerable effort in everyday life [4]. The availability and price of gluten-free products,
as well as the possible difficulties caused by the diet in social, food-related situations, could impact
negatively on the quality of life [4–7]. These challenges could eventually result in problems with
dietary compliance—particularly if the symptoms at the time of diagnosis have been unspecific or
negligible [6–8].
Age at diagnosis may have a major influence on how celiac disease and the gluten-free diet are
experienced on an individual level [9]. Pediatric patients in particular constitute a special group, as
the diet is usually initiated by the parents and maintained under their supervision until adolescence.
Furthermore, patients diagnosed in childhood may not remember their initial symptoms or the reason
for the celiac disease diagnosis [4,10], which could decrease the motivation to maintain the dietary
treatment. Sufficient knowledge about celiac disease is therefore important to optimize coping with the
disease and its long-term health outcomes. At present, however, there are limited data on how patients
diagnosed as children experience the gluten-free diet in their daily life later in adulthood [11,12].
The aim of the present study was to evaluate the prevalence and associated factors of everyday
life restrictions caused by long-term treated celiac disease. This was accomplished by comparing
currently adult patients with and without reported restrictions caused by the gluten-free diet initiated
in childhood.
2. Materials and Methods
2.1. Patients and Study Design
The study was carried out at Tampere University and Tampere University Hospital, Finland.
The basis of the study cohort was a comprehensive research database of 955 biopsy-proven celiac
disease patients diagnosed in childhood between 1966 and 2014 [12]. After excluding subjects who
were at present below 18 years of age (n = 370), deceased (n = 7), or with missing contact information
(n = 19), a specific study questionnaire and two validated questionnaires for gastrointestinal symptoms
and quality of life were sent to the remaining 559 adult patients. The responders were divided into
those who did and those did not report daily life restrictions caused by maintaining a gluten-free diet,
and all study variables were compared between these two groups (Figure 1).
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2.2. Diagnostic Features
The demographic data and the baseline clinical presentation, including symptoms and other
possible signs of untreated celiac disease such as abnormal growth and the presence of anemia, were
collected from the patient records. Anemia and growth disturbances were defined as findings, not
symptoms. The main clinical presentation was further classified as: (1) gastrointestinal symptoms, e.g.,
abdominal pain, diarrhea, vomiting, constipation, and bloating; (2) extra-intestinal manifestation, e.g.,
dermatitis herpetiformis, growth disturbances, anemia, arthralgia, and neurologic symptoms; and (3)
detection by screening at-risk groups, such as relatives of celiac disease patients and those with an
associated autoimmune disorder. The severity of the symptoms was graded as: (1) none; (2) mild,
occasionally disturbing symptoms; (3) moderate, more frequent and/or distracting symptoms; and (4)
severe, continuous symptoms seriously disturbing daily life. Poor growth was defined as an abnormal
deviation from the expected height and/or growth rate, as described elsewhere, [13] and anemia was
defined as blood hemoglobin below the age- and sex-matched reference.
The severity of diagnostic histopathology was verified from the pathology reports. In our clinical
routine, at least four duodenal biopsies are systemically taken upon esophagogastroduodenoscopy
in each case of suspected celiac disease [14]. Mucosal damage is evaluated from representative and
well-orientated mucosal specimens, and the lesion is further categorized as partial, subtotal, or total
villous atrophy, which correspond approximately to Marsh-Oberhuber 3a–c [15].
2.3. Health and Treatment-Related Outcomes in Adulthood
The adult celiac disease patients were sent three separate questionnaires. The specific study
survey was designed to evaluate the long-term health and treatment outcomes, and two well-validated
surveys were used to measure the self-perceived gastrointestinal symptoms and health-related quality
of life.
The specific study questionnaire consisted of questions regarding the current socioeconomic status,
presence of children, family history of celiac disease, and a variety of life-style factors such as smoking
and regularity of physical exercise. Furthermore, patients were asked about their current health
experiences, including possible daily life restrictions due to a gluten-free diet, health-related concerns,
presence of possible celiac disease-related symptoms, adherence to and challenges in maintaining
a gluten-free diet, and the implementation of a follow-up for celiac disease. In addition, patients were
asked about the possible presence of celiac disease-associated and other chronic disorders, regular
medication, and complications such as fractures, miscarriages, and malignancies. Daily life restrictions
due to a gluten-free diet were defined as a need to refuse an intended activity due to celiac disease.
Patients were also asked about the situations where the restrictions were encountered. Health concerns
refer to the possible experience of worries because of one’s state of health.
Self-experienced health was further classified as: (1) excellent or good; and (2) moderate or poor,
and health concerns were classified as: (1) none; (2) minor; and (3) moderate or severe. The strictness
of the dietary adherence was categorized as: (1) strict and (2) lapses more often than once a month.
The implementation of the follow-up was classified as: (1) regular, denoting visits every 1–3 years;
(2) occasional; and (3) no current follow-up.
The Gastrointestinal Symptom Rating Scale (GSRS) was used to evaluate current gastrointestinal
symptoms [16]. The questionnaire comprises 15 questions divided into five sub-dimensions, including
diarrhea, indigestion, constipation, abdominal pain, and reflux. These are scored with a seven-point
Likert scale from no symptoms (1) to the most severe symptoms (7). The values for each subcategory
are calculated as the mean of the related items, and the total score is calculated as the mean of all
15 items.
The Psychological General Well-Being (PGWB) questionnaire was used to assess the self-perceived
quality of life [17]. The validated survey contains 22 items covering six subdomains: anxiety, depressive
mood, positive well-being, self-control, general health, and vitality. Each question is scored with
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a six-point Likert scale, with higher scores indicating a better quality of life. The total score ranges
from 22 to 132 points, and the subdomain scores are calculated as the sums of selected questions.
2.4. Ethical Aspects
The study was conducted according to the Declaration of Helsinki. The Regional Ethics Committee
of the Pirkanmaa Hospital District and the Department of Paediatrics, Tampere University Hospital,
approved the data collection and questionnaire sending. Informed consent was obtained from all
patients answering the questionnaires.
2.5. Statistical Analysis
The categorical data are presented as percentages and the quantitative data as medians with
quartiles. Fisher’s exact test or the chi-squared test were used in statistical comparisons of the
categorical variables, and the Mann–Whitney U test was used in comparisons of the numeric variables.
A p-value < 0.05 was considered significant. All analyses were performed with SPSS version 24 (IBM
Corporation, Armonk, NY, USA). The data were available for at least 90% of the patients in each
variable unless otherwise stated.
3. Results
In total, 231 (41%) of the 559 adult patients responded to the questionnaires. The responders
were more often women (69% vs. 52%, p < 0.001) and, based on medical records, they more often
had a family history of celiac disease (56% vs. 44%, p = 0.029) and less coexisting type 1 diabetes (9%
vs. 16%, p = 0.038). The responders and non-responders did not differ in age at diagnosis or year of
diagnosis, main clinical presentation, severity of symptoms, degree of villous atrophy, or presence of
poor growth and anemia.
A total of 107 (46%) of the 231 responders reported daily life restrictions caused by maintaining
a gluten-free diet. These were most commonly encountered when eating at restaurants (72%), traveling
abroad (38%), and visiting friends (30%). Subjects reporting restrictions more often had anemia than
those without restrictions, but the groups were comparable in other disease features at childhood
diagnosis (Table 1) and also in the median age at diagnosis (9.7 (quartiles 4.2, 13.0) years vs. 9.7 (6.0,
13.3) years, p = 0.603), and gender distribution (girls 67% vs. 72%, p = 0.460). The presence of anemia
at childhood diagnosis also predicted a less common use of prescription medication in adulthood
(30% vs. 46%, p = 0.028), but was not associated with other follow-up characteristics such as the
employment status, family history, lifestyle, ongoing symptoms, health experiences, dietary adherence,
challenges with the diet or presence of follow-up.
Upon current evaluation, patients with and without restrictions were comparable in median age
(26.4 (21.7, 35.9) years vs. 27.7 (22.1, 30.2) years, p = 0.325) and time from the diagnosis (17.6 (12.0,
29.6) years vs. 18.6 (13.2, 31.6) years, p = 0.452), as well as socioeconomic status, membership of the
celiac society, presence of children, family history of celiac disease, frequency of physical exercise,
smoking, and use of medication (Table 2). In the detailed analysis, five patients reported a regular use
of antidepressants, and none of the five reported restrictions caused by celiac disease.
Subjects with restrictions had more health concerns and overall symptoms, such as abdominal
complaints, arthralgia, skin symptoms and tiredness. One adult patient reported anemia and loss of
hair, but she did not suffer from anemia at diagnosis. Those with restrictions found maintaining the
gluten-free diet more challenging, whereas the groups did not differ in self-experienced general health,
dietary adherence, or implementation of the follow up (Table 3). Health concerns, ongoing symptoms
and challenges with the diet were not associated with gender or the presence of a regular follow-up.
Based on the validated questionnaires, the patients with restrictions showed significantly worse
PGWB vitality scores, whereas there were no differences in other aspects of the current self-perceived
quality of life or gastrointestinal symptoms as measured by GSRS (Table 4). The prevalence of celiac
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disease-associated and other chronic comorbidities was similar for all diseases (45% vs. 47%, p = 0.771)
and for each individual disease (Supplementary Table S1).
Table 1. Clinical characteristics of 231 children upon celiac disease diagnosis with and without later
self-reported restrictions caused by a gluten-free diet (GFD) in adulthood.
Restrictions due to GFD
Yes, n = 107% No, n = 124% p-Value
Anemia 37 22 0.014
Poor growth 35 27 0.258
Main clinical presentation 0.528
Screen-detected 1 20 19
Extra-intestinal 2 31 25
Gastrointestinal 50 57
Severity of symptoms 3 0.149
None 4 32 27
Mild 31 45
Moderate 26 24
Severe 11 4
Severity of villous atrophy 0.653
Partial 34 32
Subtotal 36 42
Total 31 26
1 E.g., celiac disease in the family or presence of an associated autoimmune disorder; 2 E.g., dermatitis herpetiformis,
arthralgia, dental enamel defects, and neurologic symptoms; 3 Data available for 180 of the 231 patients; 4 Includes
asymptomatic children with clinical signs such as poor growth or anemia. Due to rounding, the percentages may
not add up precisely to 100%.
Table 2. Characteristics in 231 adults diagnosed with celiac disease in childhood with and without
self-reported restrictions caused by a gluten-free diet (GFD).
Restrictions due to GFD
Yes, n = 107% No, n = 124% p-Value
Employed 1 77 81 0.499
Member of celiac society 54 50 0.567
One or more children 45 40 0.436
Family history of celiac disease 56 65 0.180
Current or previous smoking 31 33 0.822
Prescription medication 2 38 42 0.782
Physical exercise 0.292
4−7 times per week 33 34
1−3 times per week 53 46
Less or no exercise 13 21
1 Full-time or part-time; Data available for 181 of the 231 patients; 2 E.g., asthma medication, insulin, antidepressants,
statins, and levothyroxine; contraceptives excluded. Due to rounding, the percentages may not add up precisely
to 100%.
Table 3. Current experience of health and celiac disease in 231 adults diagnosed in childhood with and
without self-reported restrictions caused by a gluten-free diet (GFD).
Restrictions due to GFD
Yes, n = 107% No, n = 124% p-Value
Celiac disease-related symptoms 1 32 17 0.006
Maintaining the diet challenging 34 9 <0.001
Experience of current health 0.998
Excellent or good 82 82
Moderate or poor 18 18
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Table 3. Cont.
Restrictions due to GFD
Yes, n = 107% No, n = 124% p-Value
Concerns about health 0.050
None 32 47
Minor 46 40
Moderate or severe 22 13
Adherence to gluten-free diet 0.760
Strict diet 93 94
Regular lapses 2 8 7
Follow up of celiac disease 0.195
Regular 30 21
Occasional 3 40 38
None 31 40
1 Based on self-assessment; 2 more than once a month; 3 less than every three years. Due to rounding, the percentages
may not add up precisely to 100%.
Table 4. Current quality of life and gastrointestinal symptoms of 231 adults diagnosed with celiac
disease in childhood with and without daily life restrictions caused by a gluten-free diet (GFD).
Restrictions due to GFD
Yes, n = 107
Median (Q1, Q3)
No, n = 124
Median (Q1, Q3)
p-Value
Psychological General Well-Being 1
Total score 103 (90, 112) 107 (96, 114) 0.188
Vitality 17 (15, 19) 18 (15, 20) 0.031
Anxiety 23 (19, 26) 24 (20, 26) 0.162
Depressive mood 17 (15, 18) 17 (15, 18) 0.206
Positive well-being 16 (14, 17) 16 (14, 17) 0.418
Self-control 16 (14, 17) 16 (14, 17) 0.134
General health 14 (11, 16) 14 (12, 17) 0.354
Gastrointestinal Symptom Rating Scale 2
Total score 1.9 (1.5, 2.5) 1.9 (1.5, 2.3) 0.166
Diarrhea 1.3 (1.0, 2.0) 1.3 (1.0, 2.0) 0.084
Indigestion 2.5 (1.8, 3.3) 2.3 (1.8, 3.0) 0.237
Constipation 1.3 (1.0, 2.0) 1.3 (1.0, 2.0) 0.694
Abdominal pain 2.0 (1.3, 2.7) 1.7 (1.3, 2.3) 0.192
Reflux 1.0 (1.0, 2.0) 1.0 (1.0, 2.0) 0.167
Higher scores denote either 1 a better self-perceived quality of life or 2 more severe gastrointestinal symptoms. Q1,
Q3: lower and upper quartiles.
4. Discussion
We found that almost half of the celiac disease patients diagnosed as children reported everyday life
restrictions due to a gluten-free diet in adulthood. The restrictive nature of celiac disease, particularly
its dietary treatment, has also been recognized in a few earlier studies [18–20], but hitherto long-term
data have been very scarce [21]. We consider it important to conduct studies focusing on adults
diagnosed in childhood as a separate group, as the age at diagnosis may affect the experiences of celiac
disease and the gluten-free diet substantially [9,22,23].
The daily life restrictions were associated with health concerns and a decreased experience of
vitality. Accordingly, it has been observed that various restrictions in the social life and the psychological
effects of dietary challenges may decrease the quality of life [20,24,25]. Although appropriately treated
celiac disease patients in general have a good health status compared to patients of many other
chronic diseases, the burden of a strict gluten-free diet can be considerable. For example, Shah and
colleagues [26] reported that celiac disease patients find that their disease and its dietary treatment
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cause even more restrictions than dialysis for end-stage renal disease. It is also important to realize that,
for currently somewhat unclear reasons, many celiac disease patients suffer from persistent symptoms
even when following a strict gluten-free diet [27,28], and these symptoms may again affect their
well-being negatively [29]. Correspondingly, we observed persistent symptoms more often among
adult patients who experience restrictions. Symptoms can continuously remind the patient about
the existence of celiac disease [27,29] and cause excessive monitoring of the diet due to the fear of an
inadvertent gluten intake, further restricting daily life [30].
The patients reported that a gluten-free diet causes restrictions particularly when eating at
restaurants, traveling, or visiting friends. Those reporting restrictions also found it harder to maintain
the diet, despite their generally good adherence. Difficulties in food-related social situations when
eating outside the home have been reported by celiac disease patients previously [18,19,22,23,31–33].
Challenges with the gluten-free diet may lead to the avoidance of situations that are considered difficult
or, in the worst case, regular dietary lapses. Although it would seem logical that a less strict diet would
at least make everyday life easier, difficulties in adherence have also been shown to be associated with
a poorer quality of life [22,33]. Insufficient knowledge about the gluten-free diet could explain the
avoidance of food-related situations and the feeling that the diet is unnecessarily difficult. Another
explanation for these could be difficulties in the financial situation as gluten-free products are often
more expensive than their gluten-containing counterparts [4]. However, the availability and selection
of gluten-free products is in general good in Finland. These issues should be further discussed, and
the patients should be educated both at diagnosis and later during follow-up visits.
On the other hand, only one-fourth of the celiac disease patients reported a regular long-term
follow-up in adulthood, and this was not associated with the experience of restrictions. This is
interesting, since one of the main reasons for recommending the routine follow-up of celiac disease
is to support coping with the demanding diet [34,35]. The effectiveness of a systematic follow-up in
facilitating the everyday monitoring of one’s own diet has been demonstrated previously in patients
with type 1 diabetes [36]. Similarly, different social coping strategies and problem-solving skills, which
could be taught during the follow-up, are thought to improve the everyday management of celiac
disease [8,31]. The fact that here the presence or lack of a follow-up did not affect the experience of
restrictions suggests the need for a more personalized approach, with a special emphasis on those with
the highest risk for future problems.
Of the plausible factors predicting the later experience of restrictions, only the presence of anemia
at diagnosis was found to have a significant association. Anemia has been associated with more
severe celiac disease [37,38], but more studies are needed to decipher whether the observation has
any clinical significance. There has been a concern that asymptomatic screening-detected patients
in particular would consider the gluten-free diet burdensome, as it often has no apparent clinical
benefits [4,7], but our findings do not support this hypothesis. However, we must remember that
pediatric patients do not necessarily recall their clinical presentation in adulthood. Overall, it seems
difficult to predict at diagnosis who will later experience restrictions and therefore needs particular
surveillance. Adolescents in particular often consider themselves as outsiders and a “burden on
others” because of their different diet [8]. The transition from pediatric to adult care might therefore be
a good opportunity to identify those who could develop future challenges and benefit from intensified
encouragement and peer support [39].
The major strength of the present study is the comprehensive long-term health data from adult
celiac disease patients diagnosed in childhood. Furthermore, all relevant diagnostic data were verified
from systemically maintained patient records, and the use of validated questionnaires for the quality of
life and gastrointestinal symptoms increases the generalizability of the results [17,27,40–42]. The rather
moderate response rate is a limitation, which may predispose to selection bias, likely toward results
that are too positive [43]. However, this risk was reduced by the similarity of the responders and
non-responders in the medical record data. Furthermore, we were able to also invite those patients to
the study who do not make regular visits to health care. The fact that most of the current characteristics
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were self-reported has both advantages and disadvantages. For example, the patients’ own assessment
may provide a more realistic picture of their quality of life compared to the physician’s evaluation [44],
but, on the other hand, the reporting of comorbidities might be less reliable.
5. Conclusions
We found everyday life restrictions caused by a gluten-free diet to be common in adult celiac
disease patients diagnosed in childhood. These restrictions were associated with challenges in
maintaining the dietary treatment, persistent symptoms, and concerns about health. We therefore
consider it important to discuss these issues during the follow-up to help dispel unnecessary worries,
even when the dietary treatment seems to be successful.
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